louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT00629785: The Analysis of BMI, Asthma Prevalence, and Lung Functions of Schoolchildren in Southern Taiwan
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Asthma
Obesity
Keywords: asthma
pulmonary function tests
obesity
Lead sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Sponsor class: OTHER
First posted: 2008-03-06
Sex: ALL
Minimum age (years): 13
Maximum age (years): 16
Standard ages: CHILD
Time perspective: RETROSPECTIVE

Brief summary: The prevalence of obesity and asthma has increased in recent decades. We investigated the relationship between body mass index (BMI) and lung function, and also tried to determine if asthma prevalence differs between obese and non-obese children. We propose this cross-sectional, retrospective analysis to figure out whether the BMI is associated with elevated prevalence of asthma, and how their lung function changes in different BMI groups.


Eligibility criteria: Inclusion Criteria:

* students representing all grades in a total of 123 junior high schools in southern Taiwan (Kaohsiung and Pintong) between 1995-1996

Exclusion Criteria:

* failure to obtain ISAAC questionnaire
* failure to preform lung functions study

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
affiliation: Faculty of Public Health, Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
name: Ying-Chin Ko
role: STUDY_CHAIR
References:
Clinical trial NCT00195585: Study Evaluating Isovorin in Colon Cancer
Official title: Post-Approved Phase III Study of 1-LV/5FU Therapy
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Colon Cancer
Keywords: Colon Cancer
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Sponsor class: INDUSTRY
First posted: 2005-09-19
Enrollment: 650
Sex: ALL
Minimum age (years): 20
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of the study is to verify superiority of 1-LV/5FU therapy to UFT Therapy of relapse-free survival time in patients with Dukes C and Cure A colon cancer. Secondary endpoints include disease-free survival time, survival time, and safety.


Eligibility criteria: Inclusion Criteria:

* Dukes C, Cure A colon cancer diagnosed histologically or cytologically
* Normal organ function of bone marrow, heart, liver and kidney
* Age 20-75

Other inclusion applies

Exclusion Criteria:

* Serious bone marrow suppression, infection, heart disease or complication
* Familial adenomatous polyposis or hereditary nonpolyposis
* Pregnant or breastfeeding women

Other exclusion applies

Primary outcomes:
measure: Relapse-free survival time
Secondary outcomes:
measure: Disease-free survival time, survival time, safety
Other outcomes:
Locations:
city: Tokyo
country: Japan
Study officials:
affiliation: Wyeth is now a wholly owned subsidiary of Pfizer
name: Medical Monitor
role: STUDY_DIRECTOR
References:
Clinical trial NCT01711437: Different Bowel Preparations for Colonoscopy In Children
Official title: EFFICACY, TOLERABILITY, AND SAFETY OF DIFFERENT BOWEL PREPARATIONS FOR COLONOSCOPY IN CHILDREN
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE4
Conditions: Colonoscopy
Keywords: colonoscopy
colon cleansing
children
age 2 -18 years
Lead sponsor: Azienda Policlinico Umberto I
Sponsor class: OTHER
First posted: 2012-10-22
Enrollment: 400
Sex: ALL
Minimum age (years): 2
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP

Brief summary: THE AIM OF THIS STUDY IS TO COMPARE THE EFFICACY, TOLERABILITY, AND SAFETY OF DIFFERENT BOWEL PREPARATIONS FOR COLONOSCOPY IN CHILDREN.

THE AIM OF THIS STUDY IS TO COMPARE THE OVERALL COLON CLEANSING

Detailed description: COLONOSCOPY IS AN ESTABLISHED DIAGNOSTIC AND THERAPEUTIC TOOL IN A VARIETY OF GASTROINTESTINAL TRACT CONDITION AFFECTING CHILDREN AND ADOLESCENTs. FOR EXAMPLE: INFLAMMATORY BOWEL DISEASE, COLONIC POLYPS OR LOWER GASTROINTESTINAL TRACT BLEEDING.

THE IDEAL PREPARATION SHOULD BE OF LOW VOLUME, PALATABLE AND SUCCESSFUL IN COMPLETE COLON CLEANOUT.

PRIMARY AIMS OF THIS WERE TO COMPARE THE EFFICACY AND ACCEPTANCE OF FOUR METHODS OF BOWEL CLEANSING BEFORE COLONOSCOPY IN CHILDREN. SECONDARY AIMS WAS TO COMPARE THE SAFETY PROFILE OF THIS METHODS.

Eligibility criteria: Inclusion Criteria:

* Patients undergoing elective colonoscopy in our Institution between 2 and 18 years of age were recruited for this study.

Exclusion Criteria:

1. requirement for urgent colonoscopy,
2. bowel obstruction,
3. known or suspected hypersensitivity to the active or other ingredients,
4. clinically significant electrolyte imbalance,
5. prior intestinal resection,
6. known metabolic, renal and cardiac disease

Primary outcomes:
measure: Efficacy
timeFrame: During the performance of colonoscopy
Secondary outcomes:
measure: safety
timeFrame: 4 days
measure: clinical tolerabiity
timeFrame: On the morning of colonoscopy, immediately before the procedure
measure: Compliance
timeFrame: On the morning of colonoscopy, immediately before the procedure
measure: Acceptability
timeFrame: On the morning of colonoscopy, immediately before the procedure
Other outcomes:
Locations:
city: Roma
country: Italy
facility: Dipartimento di pediatria e neuropsichiatria Policlinico umberto l "università di roma la sapienza"
Study officials:
References:
Clinical trial NCT00137137: The Mini-Screw as Orthodontic Anchoring: Survival, Clinical Efficiency and Experience of the Patient
Official title: The Mini-Screw as Orthodontic Anchoring: A Clinical Trial to Study Survival, Clinical Efficiency and Experience of the Patient
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Dental Implants
Lead sponsor: University Hospital, Ghent
Sponsor class: OTHER
First posted: 2005-08-29
Enrollment: 20
Sex: ALL
Minimum age (years): 10
Maximum age (years): 70
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: This is a clinical trial to evaluate the mini-screw as orthodontic anchoring. This trial will study implant survival, clinical efficiency and experience of the patient.


Eligibility criteria: Inclusion Criteria:

* 10-70 years of age

Primary outcomes:
measure: Implant survival
Secondary outcomes:
measure: Patient opinion
measure: Efficacy of treatment
Other outcomes:
Locations:
city: Ghent
country: Belgium
facility: University Hospital Ghent
Study officials:
affiliation: University Hospital, Ghent
name: Hugo De Bruyn, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT06351137: Timecost of Intranasal Versus Intravenous Analgesia in Traumatic Pain
Official title: Timecost of Intranasal Versus Intravenous Analgesia in Traumatic Pain
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Acute Pain Due to Trauma
Analgesia
Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sponsor class: OTHER
First posted: 2024-04-08
Enrollment: 19
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: TREATMENT

Brief summary: Prehospital treatment of acute traumatic pain is common in military practice. Analgesics are usually administered intravenously (IV). Research from the civil prehospital environment shows that obtaining IV access can be difficult and time consuming, delaying onset of treatment. The challenges for obtaining IV access in the military prehospital setting are even bigger, for example in combat environments. However, this has not been assessed.

Current guidelines also offer alternative routes of administration for analgesics, for example intranasal (IN) administration. IN administration is a fast, easy and effective route of administration. This study determines whether IN administration of analgesia is faster and leads to increased healthcare provider satisfaction compared to IV administration in patients with acute traumatic pain in a simulated military prehospital environment.


Eligibility criteria: Inclusion Criteria:

* All navy healthcare personnel attending (simulation) training on prehospital trauma care.

Exclusion Criteria: none

Primary outcomes:
measure: Time required for administration of analgesic (minutes)
timeFrame: During simulation training (expected <5 minutes)
Secondary outcomes:
measure: Total time spent on scene (minutes)
timeFrame: During simulation training (expected <10 minutes)
measure: Time required for obtaining IV access
timeFrame: During simulation training (expected <5 minutes)
measure: Time required preparing IN administration
timeFrame: During simulation training (expected <0.5 minute)
measure: Satisfaction of the navy nurse regarding the used route of administration.
timeFrame: Directly after completion of simulation training
Other outcomes:
Locations:
city: Amsterdam
country: Netherlands
facility: Amsterdam UMC
state: Noord-Holland
Study officials:
affiliation: Amsterdam UMC
name: Markus W Hollmann, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT01242215: A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients
Official title: A Phase III Study to Assess the Efficacy, Safety and Tolerability of ASP1941 in Combination With Sulfonylurea in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sulfonylurea Alone
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Type 2 Diabetes Mellitus
Keywords: Diabetes mellitus
sulfonylurea
ASP1941
Lead sponsor: Astellas Pharma Inc
Sponsor class: INDUSTRY
First posted: 2010-11-16
Enrollment: 243
Sex: ALL
Minimum age (years): 20
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This study is to evaluate the efficacy and safety after concomitant administration of ASP1941 and sulfonylurea in patients with diabetes mellitus.

Detailed description: This study is to evaluate the efficacy and safety of ASP1941 in combination with sulfonylurea in subjects with type 2 diabetes mellitus (T2DM) who have inadequate glycemic control with sulfonylurea alone. The effects of ASP1941 are compared with those of placebo. Double blind period continues for 24 weeks followed by open period in each patient.

Eligibility criteria: Inclusion Criteria:

* Type 2 diabetic patients receiving with sulfonylurea mono-therapy for at least 4 weeks
* HbA1c value between 7.0 and 9.5%
* Body Mass Index (BMI) 20.0 - 45.0 kg/m2

Exclusion Criteria:

* Type 1 diabetes mellitus patients
* Serum creatinine \> upper limit of normal
* Proteinuria (albumin/creatinine ratio \> 300mg/g)
* Dysuria and/or urinary tract infection, genital infection
* Significant renal, hepatic or cardiovascular diseases
* Severe gastrointestinal diseases

Primary outcomes:
measure: Change from baseline in HbA1c
timeFrame: Baseline and for 24 weeks
Secondary outcomes:
measure: Change from baseline in fasting plasma glucose
timeFrame: Baseline and for 24 weeks
measure: Change from baseline in fasting serum insulin
timeFrame: Baseline and for 24 weeks
measure: Safety as reflected by adverse events, routine safety laboratories, vital signs, physical examinations and 12-lead electrocardiograms (ECGs)
timeFrame: for 52 weeks
Other outcomes:
Locations:
city: Chubu
country: Japan
city: Chugoku
country: Japan
city: Hokkaido
country: Japan
city: Kansai
country: Japan
city: Kantou
country: Japan
city: Kyushu
country: Japan
city: Touhoku
country: Japan
Study officials:
affiliation: Astellas Pharma Inc
name: Use Central Contact
role: STUDY_CHAIR
References:
citation: Kashiwagi A, Shestakova MV, Ito Y, Noguchi M, Wilpshaar W, Yoshida S, Wilding JPH. Safety of Ipragliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials. Diabetes Ther. 2019 Dec;10(6):2201-2217. doi: 10.1007/s13300-019-00699-8. Epub 2019 Oct 12.
Clinical trial NCT03111615: HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer
Official title: Hormone Therapy Initiation Immediately After Histological Diagnosis of Breast Cancer, Can it Make Any Difference?
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE4
Conditions: Hormone Dependent Neoplasms
Breast Cancer Female
Keywords: Aromatase inhibitors
Luminal Breast Cancer neoadjuvant hormone therapy
Lead sponsor: Centro Hospitalar Lisboa Ocidental
Sponsor class: OTHER_GOV
First posted: 2017-04-13
Enrollment: 90
Sex: FEMALE
Minimum age (years): 50
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Aromatase inibitor therapy to start immediately after biopsy results are available Letrozole 2.5mg or Anastrazol 1 mg
Primary purpose: TREATMENT

Brief summary: Breast Cancer is a public health issue worldwide. The time from diagnosis to treatment initiation varies from country to country and regionally within a country. Early diagnosis and prompt treatment initiation are key factors in patient survival rates.

Currently there is a rising trend, with a high percentage of patients with "Luminal" like breast cancer only undergoing adjuvant endocrine therapy.

Authors argue that tumor biology alterations after introducing very early endocrine therapy might have a prognostic and therapeutic impact and should be studied.

Detailed description: Selected patients of female gender, above 50 y.o, and after a biopsy of Luminal-like Breast Cancer will go under aromatase inhibitor, from the diagnosis day till the surgical therapy to be decided (if so).In this study are going to be included patients that refuse surgical treatment, remaining this way in an "active surveillance". This last group is going to be randomised in order to recieve hormontherapy plus placebo vs hormontherapy plus acetolisalicilic acid.

In this way, authors want to investigate if:

1. st This approach influences the tumor biology
2. nd This approach influences tumor pathologic response and progression free survival.
3. rd It is a valid approach and in which grade, for patients that refuse surgical treatment

Eligibility criteria: Inclusion Criteria: Menopausal woman of equal or above 50 y.o. with breast biopsy of Luminal like breast carcinoma

Exclusion Criteria:

* informed consent
* \<50 y.o.
* Pre-menopausal state

Primary outcomes:
measure: Tumor Biology
timeFrame: 6 weeks
Secondary outcomes:
measure: Tumor Pathology response
timeFrame: 6 weeks
measure: Disease free survival
timeFrame: 1 5 and 10 years
measure: Hormone treatment
timeFrame: 1 5 and 10 years
Other outcomes:
measure: Surgical outome
timeFrame: 3 days 1 month and 3 months
Locations:
city: Lisbon
country: Portugal
facility: Hospital São Francisco Xavier
Study officials:
affiliation: CHLO Medical Oncology dpt
name: Vasco Fonseca, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: CHLO Surgery dpt
name: Zacharoula Sidiropoulou
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT02927015: Glucose Response From Antioxidant Rich Potato Chips
Official title: Glucose Response From Antioxidant Rich Potato Chips
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Glycemic Response
Lead sponsor: Purdue University
Sponsor class: OTHER
Collaborators: name: PepsiCo Global R&D
First posted: 2016-10-06
Enrollment: 11
Sex: ALL
Minimum age (years): 18
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: BASIC_SCIENCE

Brief summary: Assess impact of potato phytochemical on post-prandial gastric emptying and glucose release from products in a pilot human study.

Detailed description: Preclinical data obtained using an Caco-2 intestinal cell model and enzyme assays suggest phenolic-rich potato extracts decrease intestinal glucose transport. The aim is to determine if these effects extend to the the an in vivo situation. Specifically, the glycemic response following consumption of phenolic rich pigmented potatoes compared to white potatoes with lower phenolic content will be measured. Gastric emptying will also be measured to show the effects are in fact due to rate of carbohydrate digestion and intestinal glucose transport and not gastric emptying rate.

Eligibility criteria: Inclusion Criteria:

* BMI 18-25 non-smoker

Exclusion Criteria:

* BMI outside 18-25 smoker previous gastrointestinal disease or other disease

Primary outcomes:
measure: Blood Glucose
timeFrame: up to 2 hours
measure: Gastric emptying
timeFrame: up to 4 hours
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
References:
Clinical trial NCT06257615: The Effect of Post-discharge educatıon provıded vıa Tele-nursıng to Elderly patıents
Official title: The Effect of Post-discharge Education Provided Via Tele-nursing to Elderly Patients Who Had Surgery Due to Hip Fracture, on the Quality of Life and Functional Independence Levels of the Patients
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Tele-Nursing
Keywords: Functional Independence
Hip Fracture,
Post-Discharge Education,
Telenursing,
Quality of Life.
Lead sponsor: Ataturk University
Sponsor class: OTHER
First posted: 2024-02-14
Enrollment: 60
Sex: ALL
Minimum age (years): 65
Maximum age (years): 85
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: Purpose: The aim of this study is to evaluate the effect of post-discharge training given via tele-nursing to elderly patients operated for hip fracture on the quality of life and functional independence levels of the patients.

Detailed description: Materials and Methods: This randomized controlled, pretest-posttest, single-center experimental study was conducted in a hospital between August 2022 and April 2023, with 30 patients in the intervention group and 30 patients in the control group. Nursing intervention was administered to the intervention group by three educational online video calls (1st, 2nd and 3rd weeks after discharge), three educational voice phone calls (4th, 5th and 6th weeks after discharge) and It consists of a training booklet with educational content. No intervention was applied to the control group. Research data; It was collected using the Patient Introduction Form, SF-36, FIM. Informed consent was obtained from the patients and caregivers with the permission of the ethics committee and the institution. Data analysis was done using Chi-Square, Independent T-Test and Dependent T-Test.

Eligibility criteria: Inclusion Criteria:

* Being 65 years or older
* Being hospitalized and operated on with a diagnosis of hip fracture as a result of a simple fall/falling from one's own level/osteoporotic fracture
* Being literate
* Not having a visual/hearing disability that would hinder communication.
* Not having a Mental Disorder (According to the statements of the patients)
* Having a primary caregiver aged 18 and over who will cooperate throughout the research,
* Having any of the available technical equipment that allows online calls (Phone, tablet, computer, etc.).

Exclusion Criteria:

* • Having previously broken a hip and been operated on

  * Being bedridden or using walking aids before the current fracture

Primary outcomes:
measure: Quality of Life Scale
timeFrame: up to 7 weeks
Secondary outcomes:
measure: Functional Independence Scale
timeFrame: up to 7 weeks
Other outcomes:
Locations:
city: Erzurum
country: Turkey
facility: Ataturk University
Study officials:
affiliation: Ataturk University
name: Hasret Yalcinoz Baysal, Associate Prof
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT02280915: Bioavailability of Iron From Savoury Food Product
Official title: Assessment of the Bioavailability of Iron in Iron Fortified Savoury Food Product in Healthy Women
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Healthy
Iron Deficiency
Keywords: female
subjects
Lead sponsor: Unilever R&D
Sponsor class: INDUSTRY
First posted: 2014-11-02
Enrollment: 24
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: BASIC_SCIENCE

Brief summary: The study is designed to assess the bioavailability of iron from 4 different iron fortified savoury food products


Eligibility criteria: Inclusion Criteria:

* Healthy female subjects;
* Age \> 18 and \< 40 years at screening;
* Body weight \<65 kg;
* Apparently healthy: no medical conditions which might affect study measurements (judged by study physician);
* With iron deficiency (Serum ferritin \<15µg/L);
* Currently not smoking and being a non-smoker for at least six months and no reported use of any nicotine containing products in the six months preceding the study and during the study itself;
* Willing and able to participate in the study; Having given a written informed consent.

Exclusion Criteria:

* Blood donation or significant blood loss over the past 6 months;
* Reported use of any medically- or self-prescribed diet;
* Use of medication (except oral contraceptives)
* Use of vitamin or mineral supplements and unwillingness to discontinue their use two weeks prior the study and during the study;
* Is pregnant or will be planning pregnancy during the study period;
* Is lactating or has been lactating in the 6 weeks before pre-study investigation and/or during the study period;
* Known gastrointestinal or metabolic disorders;
* Participation in another clinical trial during the last 30 days prior to the beginning of the study.

Primary outcomes:
measure: To assess the absolute bioavailability of iron from 4 different iron fortified savoury food products
timeFrame: 15 days
Secondary outcomes:
measure: To assess the relative bioavailability of iron from iron fortified savoury food products
timeFrame: 15 days
Other outcomes:
Locations:
city: Zurich
country: Switzerland
facility: Laboratory of human nutrition - ETH
Study officials:
affiliation: ETH
name: Diego Moretti
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT00792415: Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool
Official title: Validation of a Pediatric Abstinence Syndrome Scoring Tool Utilizing a Standardized Hospital-Based Guideline for Iatrogenic Opioid Dependence
Study type: OBSERVATIONAL
Overall status: WITHDRAWN
Conditions: Substance Withdrawal Syndrome
Keywords: Abstinence syndrome symptoms
Withdrawal symptoms
Opioid dependence
Lead sponsor: Banner Health
Sponsor class: OTHER
First posted: 2008-11-18
Enrollment: 0
Sex: ALL
Minimum age (years): 2
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: OTHER
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Pediatric Intensive Care Unit patients

Brief summary: The purpose of this study is to assess the validity and reliability of an abstinence syndrome assessment tool used in pediatric patients with iatrogenic opioid dependence.

Detailed description: None available.

Eligibility criteria: Inclusion Criteria:

* Pediatric Intensive Care Unit patients ages 2 weeks to 18 years
* Patients receiving continuous opioid infusions for 5 days (at least 120 hours) or more

Exclusion Criteria:

* Attending discretion
* Patients with deterioration of medical status requiring interventions of pain control, surgery, sedation, or re-intubation

Primary outcomes:
measure: Total scores of abstinence syndrome symptoms
timeFrame: Up to 23 days
Secondary outcomes:
measure: Expert opinion on abstinence syndrome
timeFrame: Up to 23 days
Other outcomes:
Locations:
city: Mesa
country: United States
facility: Cardon Children's Medical Center
state: Arizona
Study officials:
affiliation: Banner Children's Hospital at Banner Desert Medical Center
name: Teri Reyburn-Orne, RN, MSN, PNP
role: PRINCIPAL_INVESTIGATOR
References: